Last reviewed · How we verify
NCT07430774: CONNECT
Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression
trial in Emotional Dysregulation in 74 participants. Not yet recruiting.
1 February 2027
Quick facts
| Lead sponsor | University of Texas Southwestern Medical Center |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 74 |
| Start date | 1 April 2026 |
| Primary completion | 1 February 2027 |
| Estimated completion | 1 May 2027 |
| Sites | 1 location across United States |
Conditions studied
- Emotional Dysregulation — all drugs for Emotional Dysregulation →
- HRV — all drugs for HRV →
- Adolescent — all drugs for Adolescent →
- Family Relationship — all drugs for Family Relationship →
Sponsor
University of Texas Southwestern Medical Center
Who can join
Adults 12 to 18, any sex, with Emotional Dysregulation or HRV. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This cross-sectional study examines associations among heart rate variability (HRV), emotional dysregulation, and parent-adolescent relationship quality in adolescents with Major Depressive Disorder (MDD). We hypothesize that lower HRV will be linked to greater emotional dysregulation and that more supportive parent-adolescent relationships will correlate with higher HRV. Participants will wear a Fitbit Charge 5 during nighttime sleep for 7 consecutive nights and complete validated measures of emotional regulation and relationship quality.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07430774
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emotional Dysregulation
Currently open trials in the same condition.
- NCT07040462 — Child-Parent Psychotherapy After the 2023 Kahramanmaraş Earthquake · NA · recruiting
Other University of Texas Southwestern Medical Center trials
Trials by the same sponsor.
- NCT03849963 — Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain · recruiting
- NCT06917183 — Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB) · NA · not yet recruiting
- NCT05145309 — Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans · Phase 2 · not yet recruiting
- NCT06552000 — Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer · NA · not yet recruiting
- NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07430774 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Texas Southwestern Medical Center
- Last refreshed: 24 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07430774.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing